Facilities

located 45 miles south of Houston

IsoTherapeutics is located 45 miles south of Houston at 1004 South Velasco Street in Angleton, Texas. The facility consists of three buildings equipped with offices, R&D laboratories, cGMP production area, documentation room, shipping and receiving, controlled storage areas and an animal research laboratory.

R&D laboratories

Fully equipped with radiochemistry and analytical equipment

R&D laboratories

Fully equipped with radiochemistry and analytical equipment
Learn More

cGMP production area

Encompassing four controlled environment rooms and a large general lab area

cGMP production area

Encompassing four controlled environment rooms and a large general lab area
Learn More
R&D Laboratories

Fully equipped with radiochemistry and analytical Equipment

radio-analytical equipment

Our radio-analytical equipment includes a variety of instrumentation including an automated NaI gamma counter along with several stand-alone NaI detectors, two germanium detectors for gamma spectroscopy, a liquid scintillation counter, an alpha spectroscopy system, dose calibrators, and many survey meters. A Siemens gamma camera allows for the capture and analysis of in vivo images.

Additional Equipment

Additional equipment includes a PerkinElmer Optima 5300 inductively-coupled plasma optical emission spectrophotometer, four chemical fume hoods, three laminar flow hoods, an HP 6890 Series GC with HP 7694 headspace sampler, an HP series 1100 HPLC with both UV and radiometric detection, an Agilent series 1200 Infinity HPLC with diode array UV and radiometric detection, an Agilent series 1200 Infinity HPLC with mass spec, variable wavelength UV and radiometric detection and a PerkinElmer Cyclone Plus Phosphor Imager, which provides autoradiography capabilities.

Biological Equipment

We have biological equipment for growing cell lines such as CO2 incubator, -80oC freezer, a certified Biological Safety Cabinet. Additional equipment includes lyophilizer, rotary evaporators, environmental chambers for product studies, steam autoclave, and various microscopes. A 96-well plate washer & reader allow us to efficiently set up ELISA assays and polyacrylamide gel electrophoresis allows for protein characterization.

cGMP Production Area

cGMP facility

The 3600 sq ft cGMP facility encompasses six controlled environment rooms and a large general lab area to assist customers with radiopharmaceutical manufacturing under the FDA guideline 21 CFR 11.

The facility is registered as a manufacturer with the FDA. The facility is equipped with the state-of-art equipment, such as class 5 lead-shielded isolators, laminar flow hoods, fume hoods, HPLC, LC-MS, autoclave, depyrogenation oven, and lyphollizer for making freeze-dried kits.

Facilities Galleries

Got a Project? Let's Schedule An Appointment

Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics

Melbourne (Australia) – 9 April 2024. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the completion of the acquisition of IsoTherapeutics Group, LLC (IsoTherapeutics).

IsoTherapeutics is a privately held, commercial-stage company that provides radiochemistry and bioconjugation development and contract manufacturing services to numerous companies in the radiopharmaceutical industry, including Telix. The acquisition further enhances Telix’s in-house development capabilities and expands Telix’s United States (U.S.) manufacturing footprint with particular focus on bioconjugation and isotope processing.

Dr Christian Behrenbruch, Managing Director and Group CEO of Telix said, “The acquisition of IsoTherapeutics Group is a significant milestone in Telix’s continued focus on vertical integration of development, supply and manufacturing and is highly complementary to Optimal Tracers (Sacramento, California), ARTMS (Vancouver) and our extensive commercial manufacturing infrastructure in Belgium. In the IsoTherapeutics team, we have partnered with some of the leading experts in radiochemistry and I am excited at what we can achieve together going forward.”